Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress March 31, 2021 Congressional R,CRS Legal Sidebar Prepared fo
药品Tag内容描述：
1、 Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress March 31, 2021 Congressional R。
2、CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i COVID19: International T。
3、 Drug Pricing and Pharmaceutical Patenting Practices Kevin T. Richards, Coordinator Legislative Attorney Kevin J. Hickey。
4、 https:crsreports.congress.gov May 17, 2019Drug Pricing and the Law: Pharmaceutical Patent DisputesPatent rights play an。
5、 https:crsreports.congress.gov May 17, 2019Drug Pricing and the Law: Regulatory ExclusivitiesThe Food and Drug Administr。
6、 Drug Pricing and Intellectual Property Law: A Legal Overview for the 116th Congress Kevin J. Hickey, Coordinator Legisl。
7、 https:crsreports.congress.gov December 27, 2018Drug Shortages: Causes, FDA Authority, and Policy OptionsDrug shortages 。
8、 Enforcement of the Food, Drug, and Cosmetic Act: Select Legal Issues ,name redacted, Legislative Attorney ,name redacte。
9、 Pharmaceutical PatentAntitrust: Reverse Payment Settlements and Product Hopping name redacted Visiting Scholar October 。
10、 Specialty Drugs: Background and Policy Concerns name redacted Analyst in Health Care Financing August 3, 2015 Congressi。
11、 Pharmaceutical Patent Settlements: Issues in Innovation and Competitiveness name redacted Visiting Scholar January 14, 。
12、 The Proposed Drug Quality and Security Act H.R. 3204 name redacted Specialist in Drug Safety and Effectiveness October 。
13、 Pharmaceutical Supply Chain Security name redacted Specialist in Drug Safety and Effectiveness October 31, 2013 Congres。
14、 Preemption of Drug and Medical Device Claims: A Legal Overview name redacted Legislative Attorney name redacted Legisla。
15、CRS Report for CongressPrepared for Members and Committees of Congress The Food and Drug Administration Safety and Innov。
16、CRS Report for CongressPrepared for Members and Committees of Congress Authorized Generic Pharmaceuticals: Effects on In。
17、CRS Report for CongressPrepared for Members and Committees of Congress Pharmaceutical Patent Litigation Settlements: Imp。
18、CRS Report for CongressPrepared for Members and Committees of Congress Intellectual Property Rights and Access to Medici。
19、CRS Report for CongressPrepared for Members and Committees of Congress Food and Drug Administration Appropriations for F。
20、1 Theses issues are described in considerable detail elsewhere. For further information, see CRSReport RL34102, FDA Legi。
